SaaS entity
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Acadia Pharmaceuticals, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window.
Last mentioned: Feb 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Acadia Pharmaceuticals, the most common co-covered peer. The 5 average consequence score is below the beat benchmark of 6.5 in the same window. They are less corroborated than the beat average, carrying 2 original sources each against 3.9 for the same window. Nuplazid appears in 1 tracked SaaS story from February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 50 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Nuplazid. Shared-story counts are live from our verified record — not editorial picks.
Alkami Technology reported strong Q4 2025 results, highlighting a significant shift toward cloud-native digital banking platforms among regional financial institutions. The company's performance, alongside ACADIA Pharmaceuticals' commercial growth, underscores a resilient market for specialized SaaS and high-margin healthcare solutions.
Nuplazid is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
